Paper513503
Reversal of renal cortical actions of angiotensin II by verapamil and manganese.
Ichikawa I and 2 others. Kidney Int, 1979. Cited by 248 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Reversal of renal cortical actions of angiotensin II by verapamil and manganese. Papers, record 513503. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/513503
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Angiotensin II | Major topic |
| Calcium | Major topic |
| Kidney Cortex | Major topic |
| Manganese | Major topic |
| Microcirculation | Major topic |
| Verapamil | Major topic |
| Animals | |
| Capillary Resistance | |
| Glomerular Filtration Rate | |
| Kidney Glomerulus | |
| Male | |
| Muscle Contraction | |
| Muscle, Smooth | |
| Rats |
Source PubMed
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 248 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 22,518,004 | Liver angiotensinogen is the primary source of renal angiotensin II. | J Am Soc Nephrol | 2012 | https://conductscience.org/library/papers/22518004 | PubMed |
| 19,948,019 | Angiotensin II in experimental hyperdynamic sepsis. | Crit Care | 2009 | https://conductscience.org/library/papers/19948019 | PubMed |
| 9,329,977 | Cellular mechanisms mediating rat renal microvascular constriction by angiotensin II. | J Clin Invest | 1997 | https://conductscience.org/library/papers/9329977 | PubMed |
| 9,257,079 | Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention. | Drugs | 1997 | https://conductscience.org/library/papers/9257079 | PubMed |
| 8,486,771 | Endothelium-derived relaxing factor/nitric oxide modulates angiotensin II action in the isolated microperfused rabbit afferent but not efferent arteriole. | J Clin Invest | 1993 | https://conductscience.org/library/papers/8486771 | PubMed |
| 7,827,397 | Do calcium channel blockers have renal protective effects? | Drugs Aging | 1994 | https://conductscience.org/library/papers/7827397 | PubMed |
| 7,364,945 | Importance of efferent arteriolar vascular tone in regulation of proximal tubule fluid reabsorption and glomerulotubular balance in the rat. | J Clin Invest | 1980 | https://conductscience.org/library/papers/7364945 | PubMed |
| 7,005,528 | The glomerulus, passive filter or regulatory organ? | Klin Wochenschr | 1980 | https://conductscience.org/library/papers/7005528 | PubMed |
| 6,733,358 | The calcium antagonists PY 108-068 and verapamil diminish the effects of angiotensin II: sites of interaction in the peripheral circulation of anaesthetized cats. | Br J Pharmacol | 1984 | https://conductscience.org/library/papers/6733358 | PubMed |
| 6,408,123 | Prostaglandin synthesis by rat glomerular mesangial cells in culture. Effects of angiotensin II and arginine vasopressin. | J Clin Invest | 1983 | https://conductscience.org/library/papers/6408123 | PubMed |
| 6,345,587 | Control of renal hemodynamics and glomerular filtration rate in chronic hypercalcemia. Role of prostaglandins, renin-angiotensin system, and calcium. | J Clin Invest | 1983 | https://conductscience.org/library/papers/6345587 | PubMed |
| 3,745,432 | Changes in glomerular hemodynamic response to angiotensin II after subacute renal denervation in rats. | J Clin Invest | 1986 | https://conductscience.org/library/papers/3745432 | PubMed |
| 3,583,608 | Protective effect of verapamil on ischaemic renal injury in dogs. | Int Urol Nephrol | 1987 | https://conductscience.org/library/papers/3583608 | PubMed |
| 3,533,999 | Sodium regulation of angiotensinogen mRNA expression in rat kidney cortex and medulla. | J Clin Invest | 1986 | https://conductscience.org/library/papers/3533999 | PubMed |
| 3,512,903 | The influence of long-term infusion of the calcium antagonist diltiazem on postischemic acute renal failure in conscious dogs. | Klin Wochenschr | 1986 | https://conductscience.org/library/papers/3512903 | PubMed |
| 3,443,059 | Clinical evaluation of felodipine in patients with refractory hypertension. | Drugs | 1987 | https://conductscience.org/library/papers/3443059 | PubMed |
| 3,262,122 | Evidence for glomerular actions of epidermal growth factor in the rat. | J Clin Invest | 1988 | https://conductscience.org/library/papers/3262122 | PubMed |
| 2,846,945 | Cellular mechanism of ischemic acute renal failure: role of Ca2+ and calcium entry blockers. | Klin Wochenschr | 1988 | https://conductscience.org/library/papers/2846945 | PubMed |
| 2,846,658 | Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome. | J Clin Invest | 1988 | https://conductscience.org/library/papers/2846658 | PubMed |
| 2,649,514 | Control of glomerular hypertension by insulin administration in diabetic rats. | J Clin Invest | 1989 | https://conductscience.org/library/papers/2649514 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/513503
GET https://conductscience.org/api/papers/v1/513503/cited_by?page=2